Emily Lagergren, MD
Vascular Surgery · Marietta, GANPI 1750678637
Payments from drug & device makers
Across 280 payments — averaging $40.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$1K
- Cook Medical LLC$978
- Medtronic$915
- Johnson & Johnson$702
- plus $4K from 30 others
What the payments were for
- Travel & lodging$1,60814%
- Food & beverage$9,80586%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 56 | $2,175 |
| W. L. Gore & Associates, Inc. | 12 | $1,395 |
| Silk Road Medical, Inc. | 14 | $1,295 |
| Cook Medical LLC | 13 | $978 |
| Medtronic(2 entities) | 39 | $915 |
| Johnson & Johnson(2 entities) | 34 | $702 |
| Bard Peripheral Vascular, Inc. | 23 | $415 |
| Smith+Nephew | 7 | $374 |
| Angiodynamics, Inc. | 10 | $355 |
| Imperative Care, Inc | 10 | $269 |
| Cardiovascular Systems Inc. | 5 | $253 |
| Stryker | 3 | $194 |
| Aroa Biosurgery Incorporated | 2 | $185 |
| Lemaitre Vascular, Inc. | 4 | $166 |
| Penumbra, Inc. | 3 | $159 |
| Kerecis Limited | 4 | $152 |
| Truvic Medical, Inc. | 1 | $149 |
| Polymedics Innovations Inc. | 1 | $118 |
| Shockwave Medical, Inc | 2 | $117 |
| Veryan Medical Incorporated | 1 | $114 |
| Organogenesis Inc. | 4 | $108 |
| Lifenet Health | 1 | $108 |
| Abbott | 2 | $104 |
| Tactile Systems Technology Inc | 2 | $94 |
| Philips North America LLC | 2 | $83 |
| E.r. Squibb & Sons, L.L.C. | 5 | $66 |
| Mozarc Medical US LLC | 2 | $63 |
| Melinta Therapeutics, LLC | 3 | $54 |
| Pfizer | 3 | $54 |
| Solventum Corporation | 3 | $49 |
| Integra Lifesciences Corporation | 2 | $36 |
| Hydrofera LLC | 2 | $35 |
| Getinge USA Sales, LLC | 2 | $28 |
| Baxter Healthcare | 1 | $24 |
| KCI USA, Inc. | 1 | $14 |
| Acera Surgical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$981
- ENROUTE Transcarotid Stent System$830
- ENHANCE Transcarotid Peripheral Access Kit$830
- ENROUTE 0.014 Guidewire$830
- GORE VIABAHN Endoprosthesis$470
- GORE VIABAHN VBX Balloon Expandable Endo$376
- GORE TAG Thoracic Branch Endoprosthesis$367
- Cook Medical Stents$238
- Endurant$194
- ENROUTE Transcarotid Stent$151
- Stravix$143
- FLOWTRIEVER CATHETER, S$137
- CT THROMBECTOMY SYSTEM KIT$137
- Heli-FX EndoAnchor System$124
- BioMimics 3D Vascular Stent System$114
- Cook Medical Zilver PTX$113
- Cook Medical Filters$113
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$112
- Cook Medical AAA$112
- Zilver PTX$111
How this compares
$11,414 in reported general payments places this provider in the 60th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $58,237 |
| XareltoRivaroxaban | 20 | $13,927 |
| Gabapentin | 22 | $488 |
| ClopidogrelClopidogrel Bisulfate | 81 | $463 |
| Atorvastatin Calcium | 44 | $271 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $174 |
| Cilostazol | 15 | $70 |
| Diazepam | 27 | $43 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $54 | $58,23772 claims |
| Johnson & JohnsonXarelto | $702 | $13,92720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Marietta
- Steven OweidaMarietta$114K
- Arun ChervuMarietta$88K
- Alykhan LalaniMarietta$64K
- Julie DukeMarietta$59K
- John PerryMarietta$40K
- Veer ChahwalaMarietta$21K
- Suman AnnambhotlaGainesville$986K
- Siddharth PatelAtlanta$381K
- Yazan DuwayriAtlanta$284K
- Houman TamaddonAugusta$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.